Doug Altman

Professor Douglas Altman Douglas Graham Altman FMedSci (12 July 1948 – 3 June 2018) was an English statistician best known for his work on improving the reliability and reporting of medical research and for highly cited papers on statistical methodology. He was professor of statistics in medicine at the University of Oxford, founder and Director of Centre for Statistics in Medicine and Cancer Research UK Medical Statistics Group, and co-founder of the international Equator Network for health research reliability. Provided by Wikipedia
Showing 1 - 20 results of 35 for search 'Douglas G. Altman', query time: 0.03s Refine Results
  1. 1
    Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals.

    Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. by Allison Hirst, Douglas G Altman

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Four Proposals to Help Improve the Medical Research Literature.

    Four Proposals to Help Improve the Medical Research Literature. by David Moher, Douglas G Altman

    Published 2015-09-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles.

    Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles. by Peggy Sekula, Susan Mallett, Douglas G Altman, Willi Sauerbrei

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Key issues in conducting a meta-analysis of gene expression microarray datasets.

    Key issues in conducting a meta-analysis of gene expression microarray datasets. by Adaikalavan Ramasamy, Adrian Mondry, Chris C Holmes, Douglas G Altman

    Published 2008-09-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

    Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. by David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman, PRISMA Group

    Published 2009-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Assessment of the Incremental Benefit of Computer-Aided Detection (CAD) for Interpretation of CT Colonography by Experienced and Inexperienced Readers.

    Assessment of the Incremental Benefit of Computer-Aided Detection (CAD) for Interpretation of CT Colonography by Experienced and Inexperienced Readers. by Darren Boone, Susan Mallett, Justine McQuillan, Stuart A Taylor, Douglas G Altman, Steve Halligan

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository.

    Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository. by Catrin Tudur Smith, Kerry Dwan, Douglas G Altman, Mike Clarke, Richard Riley, Paula R Williamson

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Multi-reader multi-case studies using the area under the receiver operator characteristic curve as a measure of diagnostic accuracy: systematic review with a focus on quality of data reporting.

    Multi-reader multi-case studies using the area under the receiver operator characteristic curve as a measure of diagnostic accuracy: systematic review with a focus on quality of da... by Thaworn Dendumrongsup, Andrew A Plumb, Steve Halligan, Thomas R Fanshawe, Douglas G Altman, Susan Mallett

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology.

    COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology. by Olaf M Dekkers, Jan P Vandenbroucke, Myriam Cevallos, Andrew G Renehan, Douglas G Altman, Matthias Egger

    Published 2019-02-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey.

    Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey. by Sarah L Gorst, Elizabeth Gargon, Mike Clarke, Jane M Blazeby, Douglas G Altman, Paula R Williamson

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice.

    Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice. by Gavin B Stewart, Douglas G Altman, Lisa M Askie, Lelia Duley, Mark C Simmonds, Lesley A Stewart

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (ENDING)

    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (ENDING) by Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. Gtzsche, Thomas Lang

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement.

    Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. by Hugh MacPherson, Douglas G Altman, Richard Hammerschlag, Li Youping, Wu Taixiang, Adrian White, David Moher, STRICTA Revision Group

    Published 2010-06-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Core Outcome Set-STAndards for Development: The COS-STAD recommendations.

    Core Outcome Set-STAndards for Development: The COS-STAD recommendations. by Jamie J Kirkham, Katherine Davis, Katherine Davis, Douglas G Altman, Jane M Blazeby, Mike Clarke, Sean Tunis, Paula R Williamson

    Published 2017-11-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (PART II)

    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (PART II) by Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. Getzsche, Thomas Lang, N. Chipigina

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001)

    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) by Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. G tzsche, Thomas Lang, N. Chipigina

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (CONTINUATION)

    THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (CONTINUATION) by Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. G tzsche, Thomas Lang, N. Chipigina

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials.

    Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials. by Kerry Dwan, Douglas G Altman, Mike Clarke, Carrol Gamble, Julian P T Higgins, Jonathan A C Sterne, Paula R Williamson, Jamie J Kirkham

    Published 2014-06-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist.

    Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. by Karel G M Moons, Joris A H de Groot, Walter Bouwmeester, Yvonne Vergouwe, Susan Mallett, Douglas G Altman, Johannes B Reitsma, Gary S Collins

    Published 2014-10-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Reporting and methods in clinical prediction research: a systematic review.

    Reporting and methods in clinical prediction research: a systematic review. by Walter Bouwmeester, Nicolaas P A Zuithoff, Susan Mallett, Mirjam I Geerlings, Yvonne Vergouwe, Ewout W Steyerberg, Douglas G Altman, Karel G M Moons

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: